Individuals given Standard Bolus for Type 1 Diabetes

Phase-Based Progress Estimates
Type 1 DiabetesStandard Bolus - Device
18 - 30
All Sexes
What conditions do you have?

Study Summary

This trial looks at how quickly insulin works in the body.

Eligible Conditions
  • Type 1 Diabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 5 minutes

5 minutes
time to reach 25% maximum insulin levels
up to 5 hours
Earlier clearance of exogenous insulin.

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Individuals given Standard Bolus
1 of 2
Individuals given Quick bolus
1 of 2

Active Control

15 Total Participants · 2 Treatment Groups

Primary Treatment: Individuals given Standard Bolus · No Placebo Group · N/A

Individuals given Standard Bolus
ActiveComparator Group · 1 Intervention: Standard Bolus · Intervention Types: Device
Individuals given Quick bolus
ActiveComparator Group · 1 Intervention: Quick Bolus · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 minutes

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,680 Previous Clinical Trials
21,088,244 Total Patients Enrolled
Eda Cengiz, MDPrincipal InvestigatorYale University
3 Previous Clinical Trials
63 Total Patients Enrolled

Eligibility Criteria

Age 18 - 30 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Insulin should be administered in dosages that range from 0.6 to 1.2 units per kilogram of body weight per day.
is required To be diagnosed with T1D, you must have experienced the condition for at least one year.
Basal Insulin CSII therapy is a type of insulin therapy in which insulin is delivered continuously to the body through a small, portable pump
A person must weigh at least 37.9 kg to be able to ride this ride.
is mandatory Having the ability to understand written and spoken English is a requirement.